When did the transition from WIPO ST.25 to WIPO ST.26 occur?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice.
The transition from WIPO ST.25 to WIPO ST.26 for sequence listings in patent applications occurred on July 1, 2022. As stated in MPEP § 2431:
“This section is not applicable to applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).”
For applications filed on or after this date, applicants must follow the WIPO ST.26 standard, which is covered in MPEP §§ 2412 – 2419.
Topics:
MPEP 2400 - Biotechnology
MPEP 2431 - Sample "Sequence Listing" Under Wipo St.25
Patent Law
Patent Procedure